These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28446459)
41. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Omote K; Gohda T; Murakoshi M; Sasaki Y; Kazuno S; Fujimura T; Ishizaka M; Sonoda Y; Tomino Y Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1335-47. PubMed ID: 24647715 [TBL] [Abstract][Full Text] [Related]
42. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Gao Q; Qin WS; Jia ZH; Zheng JM; Zeng CH; Li LS; Liu ZH Planta Med; 2010 Jan; 76(1):27-33. PubMed ID: 19639539 [TBL] [Abstract][Full Text] [Related]
43. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy. Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372 [TBL] [Abstract][Full Text] [Related]
44. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis. Ndisang JF; Jadhav A Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713 [TBL] [Abstract][Full Text] [Related]
45. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model. Yu J; Dong R; Da J; Li J; Yu F; Zha Y Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283 [TBL] [Abstract][Full Text] [Related]
47. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model. Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy. Zhao B; Li H; Liu J; Han P; Zhang C; Bai H; Yuan X; Wang X; Li L; Ma H; Jin X; Chu Y J Am Soc Nephrol; 2016 Sep; 27(9):2597-608. PubMed ID: 26839366 [TBL] [Abstract][Full Text] [Related]
49. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798 [TBL] [Abstract][Full Text] [Related]
50. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Lim AK; Ma FY; Nikolic-Paterson DJ; Kitching AR; Thomas MC; Tesch GH Diabetologia; 2010 Aug; 53(8):1772-82. PubMed ID: 20422398 [TBL] [Abstract][Full Text] [Related]
51. Cytokine Signaling Protein 3 Deficiency in Myeloid Cells Promotes Retinal Degeneration and Angiogenesis through Arginase-1 Up-Regulation in Experimental Autoimmune Uveoretinitis. Chen M; Zhao J; Ali IHA; Marry S; Augustine J; Bhuckory M; Lynch A; Kissenpfennig A; Xu H Am J Pathol; 2018 Apr; 188(4):1007-1020. PubMed ID: 29452101 [TBL] [Abstract][Full Text] [Related]
52. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088 [TBL] [Abstract][Full Text] [Related]
53. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy. Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934 [TBL] [Abstract][Full Text] [Related]
54. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Zhang H; Saha J; Byun J; Schin M; Lorenz M; Kennedy RT; Kretzler M; Feldman EL; Pennathur S; Brosius FC Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1071-81. PubMed ID: 18667486 [TBL] [Abstract][Full Text] [Related]
56. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669 [TBL] [Abstract][Full Text] [Related]
57. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365 [TBL] [Abstract][Full Text] [Related]